HGH, GRENAA A/S: Financial statements 2022
CVR: 33120753
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
HGH, GRENAA A/S (CVR 33120753) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,188 and a net result of DKK 3,936 compared with DKK -9,386 the year before. Equity in the 2022 report amounted to DKK 793,543. The solvency ratio was 53.3%.
- Gross Profit
- DKK -6,188
- Profit/Loss
- DKK 3,936
- Equity
- DKK 793,543
- Total Assets
- DKK 1,487,500
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -6K | 4K | 794K | - |
| 2021 | - | - | -9K | 790K | 0 |
| 2020 | - | - | -346K | 799K | 0 |
| 2019 | - | - | -252K | 1.1M | - |
| 2018 | - | - | -72K | 1.4M | - |
Official annual report
Keep an eye on HGH, GRENAA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 21, 2022, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of HGH, GRENAA A/S.
As of September 21, 2022, Dansk Revision Grenaa, Statsautoriseret revisionsvirksomhed has stepped down as auditor of HGH, GRENAA A/S.
HGH, GRENAA A/S has published its annual report for 2021. The net result was DKK -9,386.
About HGH, GRENAA A/S
HGH, GRENAA A/S is a Danish company of the type Aktieselskab based in Grenaa, founded in 2010. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Louise Rørbæk Jensen. The board consists of Mette Rørbæk Jensen (chair), Jess Stegger and Louise Rørbæk Jensen. The company is owned by Boet efter Ulla Merethe Rørbæk Jensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,125 and a net result of DKK -1,506,927 compared with DKK 84,836 the year before. Equity in the 2025 report amounted to DKK -789,690.